“The company has decided to boost organic growth with M&A to aide expansion. Having started off this double growth path, Pierrel could evaluate potential acquisitions with an industrial rationale” CEO Fulvio Citaredo said.
“In this scenario, it would consider niche bolt-ons in the dental anaesthetics space rather than transformational deals. The company does not have a time frame for potential new deals, as it is now fully concentrating on the integration of the recent German acquisition”, he added.
Read the complete article by Mergermarket, click here.